Description:

Sermorelin (GHRH 1–29) — Growth Hormone Axis Research Peptide

Sermorelin is a laboratory-engineered fragment of growth hormone–releasing hormone (GHRH 1–29) studied for its ability to stimulate endogenous growth hormone (GH) secretion via pituitary signaling. Originally utilized as a clinical probe of GH axis function, it is now widely explored in non-clinical research models examining endocrine regulation and downstream physiological pathways.

Research areas of interest include:

• Pituitary–GH axis signaling and pulsatile growth hormone release models
• Skeletal integrity and bone remodeling research
• Cognitive, neuroprotective, and neurologic pathway investigations
• Cardiac remodeling and tissue repair studies
• Performance, recovery, and endocrine adaptation research models

This 10 mg presentation supports controlled, repeatable laboratory study designs, making it suitable for extended investigations across endocrine regulation and recovery-focused research pathways.

Intended Use:

For laboratory research use only. Not for human or veterinary use.